The research here will mainly concentrate on the manufacturing process of biopharmaceuticals, especially in the area of advanced medicines, as well as the fermentation-based manufacture of ingredients for foods and food supplements
First and only PARP inhibitor to improve invasive disease-free survival in patients
This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
The IDCF programme is being implemented from 13th June to 27th June, 2022 in the states/UTs and the goal is to attain zero child deaths due to childhood diarrhoea
Doubling of median overall survival seen in QuANTUM-First results presented at EHA Presidential Symposium
Cantourage introduces second Clever Leaves medical cannabis product to the German market
Centre of Excellence at Kharel comprises Skill-building Centre and Primary, Secondary and Higher Secondary schools
TP-3654 is currently being evaluated in a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics in patients with intermediate or high-risk primary or secondary myelofibrosis.
Subscribe To Our Newsletter & Stay Updated
